Annual report pursuant to Section 13 and 15(d)

Acquisition of Aquarius Biotechnologies, Inc. (now Matinas Biopharma Nanotechnologies, Inc.) - Schedule of Fair Value of Contingent Transferred in Acquisition (Details) (Parenthetical)

v3.8.0.1
Acquisition of Aquarius Biotechnologies, Inc. (now Matinas Biopharma Nanotechnologies, Inc.) - Schedule of Fair Value of Contingent Transferred in Acquisition (Details) (Parenthetical) - Aquarius Biotechnologies, Inc. [Member]
Jan. 29, 2015
$ / shares
shares
Business acquisition, equity interest issued or issuable, number of shares | shares 4,608,020
Price per share | $ / shares $ 0.46